转谷氨酰胺酶是 Ca2+ 依赖性酶,可通过脱酰胺、转酰胺或酯化来催化蛋白质的翻译后修饰,将蛋白质结合的 L-谷氨酰胺的 γ-羧酰胺基团转移到一级胺上。转谷氨酰胺酶超家族包括 TGM1-7 和因子 XIIIA,其中转谷氨酰胺酶 2 (TG2) 也称为组织转谷氨酰胺酶 (tTG),是最丰富且研究最广泛的成员。TG2 在组织中发挥多种作用,在肝脏和细胞质中高度表达,而其他同工型则表现出组织特异性表达:上皮组织中的 TG1、TG3 和 TG5;前列腺中的 TG4;血液中的因子 XIII (FXIII);脑、肺和睾丸中的 TG6;以及主要在睾丸和肺中的 TG7。 TG2 与多种人类疾病有关,包括先兆子痫、高血压、心血管疾病、器官纤维化、癌症、神经退行性疾病(如阿尔茨海默病)和乳糜泻(在这些疾病中,TG2 是一种关键的自身抗原)。该酶家族的功能多样性和病理相关性使其成为治疗研究的关键焦点[1][2]。
Transglutaminases are Ca²⁺-dependent enzymes that catalyze post-translational modifications of proteins by deamidation, transamidation, or esterification, transferring the γ-carboxamide group of protein-bound L-glutamine to primary amines. The transglutaminase superfamily includes TGM1-7 and Factor XIIIA, with Transglutaminase 2 (TG2), also known as tissue transglutaminase (tTG), being the most abundant and extensively studied member. TG2 plays diverse roles across tissues and is highly expressed in the liver and cytosol, while other isoforms exhibit tissue-specific expression: TG1, TG3, and TG5 in epithelial tissues; TG4 in the prostate gland; Factor XIII (FXIII) in blood; TG6 in the brain, lungs, and testis; and TG7 predominantly in the testis and lungs. TG2 has been implicated in a wide range of human diseases, including preeclampsia, hypertension, cardiovascular disease, organ fibrosis, cancer, neurodegenerative disorders such as Alzheimer's disease, and celiac disease, where it acts as a key autoantigen. This enzyme family’s functional diversity and pathological relevance make it a critical focus for therapeutic research[1][2].
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号